Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06386198 · ClinicalTrials.gov registry record · NA
HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
A NA study of Pediatric ALL and Liver Transplant, Complications, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT06386198 is a NA study of Pediatric ALL and Liver Transplant, Complications that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 1,647-participant average among 21 other Pediatric ALL trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06386198, a NA study of Pediatric ALL and Liver Transplant, Complications, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.
Conditions Studied
Interventions
- BEHAVIORAL Health Advocate
Study Locations (2)
California
- University of California San Francisco - San Francisco
Georgia
- Children's Healthcare of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-03-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06386198
The ClinicalTrials.gov registry entry for NCT06386198 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,647-participant average among 21 other Pediatric ALL trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Health Advocate is the first listed.
NCT06386198 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Georgia.
Frequently Asked Questions
What is clinical trial NCT06386198 about?
NCT06386198 is a clinical study titled "HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients". The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their...
What is the current status of trial NCT06386198?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-03. Estimated completion is 2026-06-30.
What conditions does trial NCT06386198 study?
This clinical trial studies the following conditions: Pediatric ALL, Liver Transplant, Complications.
What interventions are being tested in trial NCT06386198?
The interventions under investigation include: Health Advocate (BEHAVIORAL).
Who is sponsoring clinical trial NCT06386198?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06386198 being conducted?
This trial has 2 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
HEalth Advocate for Liver Transplant - Pilot
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.